OQROGet OQRO Pro
Politician trade (House)

Danaher Corporation (DHR)Rep. Rob Bresnahan (PA08) disclosed a sale $15K–$50K

Rep. Rob Bresnahan (PA08) disclosed a sale of Danaher Corporation in the $15K–$50K range.

$15,001–$50,000
Reported range · official band, not an exact amount
30 days
Disclosure lag
Traded
Feb 25, 2025
Disclosed
Mar 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 8, 2015CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  2. Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  3. Jan 30, 2025InsiderOfficer sold ~$1.28M of DHR shares in the open market
  4. Feb 7, 2025InsiderDirector sold ~$114K of DHR shares in the open market
  5. Feb 13, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  6. Feb 25, 2025 · this disclosureCongressDisclosed sale of DHR — reported range $15,001 - $50,000

What came next

  1. Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  2. Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  3. Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  4. Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  5. Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
  6. Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  7. Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  8. Apr 23, 2025FDARecall: Apo B Reagent, REF: OSR6143
  9. Apr 23, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software version 1.20
  10. Apr 30, 2025FDARecall: Sample probe sucks a sample dispensed into a tube or cup and discharges the appropriate amount into a cuvette. Lot 178713114 - 179433670
  11. Apr 30, 2025FDARecall: Sample probe sucks a sample dispensed into a tube or cup and discharges the appropriate amount into a cuvette. Lot 178713114 - 179433670
  12. Apr 30, 2025Insider · 1 personInsiders: 2 sales (~$3.1M)
  13. May 5, 2025FDARecall: Access Testosterone assay, Catalog Number 33560
  14. May 7, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer C11137
  15. May 12, 2025Insider · 1 personInsiders: 8 sales (~$245.9M)
  16. May 12, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  17. May 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
  18. Jun 12, 2025FDARecall: Estrone RIA, REF: DSL8700. Estrone RIA is an IVD used for the quantitative measurement of estrone in human serum and plasma.
  19. Jun 12, 2025CongressDisclosed sale of DHR — reported range $50,001 - $100,000
  20. Jun 16, 2025FDAFDA device clearance: Access hsTnI
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Rep. Rob Bresnahan (PA08)

The full history of Rep. Rob Bresnahan (PA08) is on the profile page.

How this filing works

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data